The mechanism of iota-carrageenan (t-CAR)-induced protection against murine cytomegalovirus (MCMV) infection of mice was analysed. The virus titres in the target organs on the fourth day correlated with that in the plasma at 1 h after intraperitoneal inoculation of MCMV, irrespective of t-CAR treatment. Pretreatment of mice with z-CAR induced infiltration of polymorphonuclear neutrophils into the peritoneal cavity and inhibition of viral spread from the peritoneal cavity to the plasma. Although the direct relationship of these two phenomena was unclear, the inhibition by t-CAR of viral spread resulted in protection against MCMV infection of mice.
Introduction
Human cytomegalovirus (HCMV) sometimes causes terminal infection in fetuses, neonates and immunosuppressed patients, such as patients with organ transplants, malignancy or AIDS (Griffiths, 1990; Gold & Nankervis, 1989) . However, no animal model is available for studying antivirals against HCMV in vivo because of its strict species-specificity. Murine cytomegalovirus (MCMV) infection in the mouse simulates HCMV infection in the human counterpart (Osborn, 1982) . Therefore, we have studied pathogenesis of MCMV Minamishima et al., 1978) and the effects of antiviral substances against MCMV infection in the murine system (Ebihara & Minamishima, 1984; Okada & Minamishima, 1987a, b; Ohashi et al., 1988 Ohashi et al., , 1989 Ibusuki & Minamishima, 1990; Eizuru et al., 1992) . Various biological response modifiers (BRM), such as OK-432, PS-K, Lactobacilhts casei and Chlorella vutgaris extracts were found to have antiviral activity in our laboratory. Pretreatment of mice with the BRM protected the mice from lethal MCMV infection, and the antiviral effect seemed to be based on augmentation and preservation of natural killer (NK) activity after MCMV infection.
Pretreatment of mice with iota-carrageenan 0-CAR), a sulphated polygalactose, also protected mice from lethal MCMV infection (Hamasuna et al., 1993) . The protective effect of t-CAR was evidenced by an increase in the LD~0 value and a decrease in the titre of infectious virus in the target organs. However, the protection by t-CAR was observed only when z-CAR was administered intraperitoneally (i.p.) and then MCMV was also inoculated i.p. In contrast with other BRM, the z-CARinduced protection did not seem to be based on augmentation and preservation of NK activity. In this study, the mechanism of the protection by z-CAR was investigated with specific reference to the spread of viruses from the peritoneal cavity to the entire body of mice.
Methods
Carrageenan. Carrageenans examined for protective effects included t-CAR (type V, Sigma), lambda-carrageenan (2-CAR: type IV, Sigma) and kappa-carrageenan (~c-CAR; type III, Sigma). Each was dissolved in sterilized physiological saline and boiled for 30 rain before use. Then 0-5 nag of each CAR in 0.2 ml saline was administered i.p. to individual mice.
Mice. Female ICR mice were purchased from Kiwa Laboratory Animals. They were used for experiments at 5 weeks of age. Experiments were carried out at the Experimental Animal Center, Miyazaki Medical College.
Cells' and medium. Mouse embryonic fibroblasts (MEF) were prepared by trypsinization of 14-to 18-day-old embryos of ICR mice, and MEF were used at passages 2 to 4 for virus assay. They were grown in Eagle's MEM (Nissui Pharmaceutical) supplemented with 5 % calf serum (Flow Laboratories), 60gg/ml of kanamycin and 0.12% NaHCO 3.
Viruses. The Smith strain of MCMV was used throughout the experiments. MCMV serially passaged in the salivary glands of ICR mice was used as virulent MCMV. The virus stocks were prepared as described previously (Hamasuna et al., 1993) .
Virus hloculation. The stock of MCMV was diluted to an appropriate dose in Eagle's MEM. A suspension of MCMV was inoculated into individual mice, either administered as 0.3 ml i.p. or 0.2 ml intravenously (i.v.).
Titration of viruses.
Confluent monolayers of MEF in plastic 24-well tissue culture plates (Coming 25820, Corning Glass Works) were inoculated in duplicate with 0.1 ml of serial 10-fold dilutions of MCMV. After adsorption for 1 h, the monolayers were overlaid with Eagle's MEM containing 5% calf serum, 60 gg/ml of kanamycin, 0.12 % NaHCO a and 2.25 % methyl cellulose. After incubation at 37 °C for 4 days in a humid atmosphere containing 5 % CO~, the methyl cellulose overlay was removed and the cells were stained with 0.03 % methylene blue. The number of plaques was counted using an inverted microscope.
Titration of viruses in the peritoneal cavity. Infected mice were anaesthetized with ether, and 5 ml of RPMI 1640 medium (Flow Laboratories) was injected into the peritoneal cavity of individual mice at various times after the MCMV challenge. After massage of the abdomen, 3,5 ml of medium was recovered from each mouse. The peritoneal lavage fluid from each mouse was filtered through a membrane with a pore size of 0.45 lain (Sartorius). The infectious virus in the filtrate was titrated with MEF as described above. The virus titre was expressed as p.f.n, per ml of the peritoneal lavage fluid of individual mice.
Titration of viruses in the blood plasma. Heparinized blood was collected from the groin artery of individual mice at various times after MCMV challenge, Blood from each mouse was put into a microcentrifuge test tube (Treff Laboratory) and centrifuged at 1670g for 10 min. Plasma (0.1 ml) was diluted with 0-9 ml of Hanks" balanced salt solution and the diluted plasma was filtered as described above. The infectious virus in the plasma was fitrated with MEF as described above. The virus titre was expressed as p.f.u, per 0.1 ml of the plasma of individual mice.
Titration of viruses in the target organs.
Mice were sacrificed by cervical dislocation on the fourth day after the MCMV challenge and the target organs were aseptically removed. Ten percent homogenates of the individual organs in Eagle's MEM were centrifuged at 1160 g for 10 min. The infectious virus in the supernatant fluid was titrated with MEF as described above. The virus titre was expressed as p,f.u, per organ of individual mice.
Isolation of mononuclear cells and polymorphonuclear neutrophils from peritoneal exudate or peripheral blood.
Macrophages and polymorphonuclear neutrophils (PMN) were prepared separately from peritoneal exudate cells (PEC) by a discontinuous one-step FicollHypaque gradient centrifugation (Kalmar et al., 1988) . Briefly, 2 ml of Histopaque 1077 (specific gravity 1.077, HP; Sigma) was layered on 3 ml of Mono-Poly resolving medium (specific gravity 1'114, MPRM; ICN Biochemical) in 15 ml conical bottomed polystyrene tubes (Iwaki Glass) (MPRM-HP discontinuous centrifugation system). The peritoneal lavage fluid was layered on the MPRM-HP discontinuous centrifugation system. Two bands were obtained after centrifugation at 500 g for 30 rain at room temperature. The upper and lower bands were collected separately and washed three times with Eagle's MEM supplemented with 5 % calf serum. Cells were examined and identified after staining with May-Giemsa solution. The cells from the upper band consisted of > 95 % macrophages and the cells from the lower band of > 90 % PMN. Mononuclear cells and PMN were prepared from heparinizcd peripheral blood in a similar manner.
Infectious centre assay. At 1 mad 6 h after the MCMV challenge, macrophages and PMN from the peritoneal cavities or mononuclear cells and PMN from the peripheral blood were prepared as described above. Each cell suspension (5.0 x l0 b cells) was cocultured with monolayered MEF under the methyl cellulose overlay for 4 days at 37 °C. After the methyl cellulose layer had been removed, the plaques were stained with 0.03 % methylene blue. The number of infectious centres was counted with an inverted microscope.
Statistical analysis. The titres of infectious viruses in the peritoneal
cavity, plasma or target organs were statistically compared by the Mann-Whitney U-test.
Results

Infectious viruses in the peritoneal cavi O,
I-CAR was administered i.p. to individual mice on day 2 before the i.p. challenge with 3 LDs0 of MCMV (2"6 × 106 p.f.u.). To examine clearance of cell-free MCMV from the peritoneal cavity, the infectious virus in the peritoneal lavage fluid was titrated at various times after MCMV challenge (Fig. 1) . The cell-free infectious virus titres in the peritoneal cavity decreased more slowly in /-CARtreated mice than those in untreated mice.
In/-CAR-treated mice, the number of PEC increased and more than 40 % of them were PMN, whereas more than 99% were macrophages in untreated mice. Mice were administered 0.5 mg of t-CAR i.p. on day 2 before i.p. challenge with 3 LD~0 of MCMV. Results were expressed as the geometric mean virus titres + S.D. of five mice. ,, P < 0.05.
examine the association of MCMV with cells, macrophages and PMN were isolated at 1 and 6 h after the i.p. challenge with 3 LD~0 of MCMV (2.6 × 106 p.f.u.) and the cell-associated virus was determined by infectious centre assay (Table 1 ). The infectious centres for macrophages were 20-fold higher in 1-CAR-treated mice than those in untreated mice at 1 h after MCMV challenge, and this was maintained up to 6 h after challenge. Additionally, infectious centres for PMN were one-third of those for macrophages in ~-CAR-treated mice, though the number of infectious centres for PMN in untreated mice was not determined because of the small number of PMN
Appearance of infectious virus in the plasma
To determine when MCMV inoculated i.p. appeared in the bloodstream, the infectious virus in the plasma was titrated at various times after the MCMV challenge (Fig.   2 ). In untreated mice, infectious virus was detected 30 min after challenge and the titre peaked at 1 h. In t-CAR-treated mice, infectious virus was also detected 30 min after challenge. However, the titre of infectious virus in the plasma was apparently less than that in untreated mice until 2 h after challenge. Thus, t-CAR treatment inhibited early spread of MCMV from the peritoneal cavity to the blood. To examine the participation of leukocytes in this spread to the blood, mononuclear cells and PMN were isolated from the peripheral blood 1 and 6 h after the MCMV challenge, and the cell-associated virus was titrated by infectious centre assay. The infectious centres for leukocytes in the peripheral blood were almost negligible in both t-CAR-treated and untreated mice (data not shown).
Relationship of virus titre in the plasma to that in the target organ
When 3 LDs0 of MCMV (2.6 × 106 p.f.u.) was inoculated i.p. into individual mice, the titre of infectious virus in the plasma peaked at 1 h after MCMV challenge. The maximum titre in the plasma was 5.0 × 10 ~ p.f.u./0.1 ml and 1.5x 104 p.f.u./0.1 ml in t-CAR-treated and untreated mice, respectively. The volume of plasma was approximately 1 ml for a 22 g mouse (Wish et al., 1950) . Therefore, it was presumed that the circulating MCMV in individual mice was 5"0 x 103 p.f.u, and 1.5 × 105 p.f.u. in t-CAR-treated and untreated mice, respectively. When untreated mice were inoculated i.v. with 1.5 × 105 p.f.u, of MCMV, the titre of MCMV in the lung was almost equivalent to that found in untreated mice inoculated i.p. with 3 LDs0 of MCMV (2.6 x 106 p.f.u.) (Fig. 3) . In the same way, the titre in t-CAR-treated mice inoculated i.v. with 5"0 × 103 p.f.u, was almost equivalent to that in the t-CAR-treated mice inoculated i.p. with 3 LDs0 of MCMV. Those results supported our presumption that the amount of circulating MCMV was reasonable in both groups of mice.
The virus titres in the lungs of t-CAR-treated mice Relationship between virus titre in the plasma and that in the lung. The lung was aseptically removed on day 4 after MCMV challenge and infectious virus in the lung was plaque-titrated. As for the inocula of MCMV, a dose of 2-6 × 10 6 p.f.u, was 3 LD~0 for untreated mice, when inoculated i.p. Titres of 1-5× 10 5 p.f.u, and 5.0 x 10 3 p.f.u, were the presumptive amount of circulating MCMV in untreated and l-CAR-treated mice, respectively, when 2.6 × 10 6 p.f.u, of MCMV had been inoculated i.p. Results were expressed as the geometric mean virus titres+s.D, of three mice. ? Number of PMN/number of PEC. Mean values of three mice. :~ Blood was collected from the groin artery of individual mice at 1 h after the MCMV challenge, heparinized and the infectious virus in the plasma was plaque-titrated. Virus titres are expressed as the geometric mean_+s.D, of five mice.
§ The target organs were aseptically removed on the fourth day after MCMV challenge and the infectious virus in the organs was plaque-titrated. Virus titres are expressed as the geometric mean _+ S.D. of five mice.
I] Virus titre statistically significantly less than that in untreated mice (P < 0.05). t Number of PMN/number of PEC. Mean values of three mice. Blood was collected from the groin artery of individual mice at 1 h after the MCMV challenge, heparinized and the infectious virus in the plasma was plaque-titrated. Virus titres are expressed as the geometric mean-t-s.o. of three mice.
§ The target organs were aseptically removed on the fourth day after MCMV challenge and the infectious virus in the organs was plaque-titrated. Virus titres are expressed as the geometric mean_+ S.D. of three mice.
[I The difference in the titres was statistically significant compared to untreated control mice (P < 0.05). inoculated i.v. with 1"5 x 105 p.f.u, of MCMV were equivalent to those in untreated mice inoculated i.p. with 3 LDs0 of MCMV. Thus, the titre of infectious virus in the lung correlated with the amount of circulating MCMV in both t-CAR-treated and untreated mice.
The time-efficacy relationship between t-CAR treatment and MCMV challenge
I-CAR was administered i.p. to mice at various times prior to the MCMV challenge, and the effect of t-CAR was examined (Table 2 ). When i-CAR was administered to mice more than 18 h prior to the virus challenge, PMN infiltrated into the peritoneal cavity and constituted more than 40% of PEC. In addition, the spread of viruses from the peritoneal cavity to the plasma was inhibited and subsequently the virus titres in the target organs were reduced. 1 h and that in the target organs on the fourth day after i.p. MCMV challenge were examined (Table 3) . In 2-CAR-treated mice, PMN infiltrated into the peritoneal cavity and the viral spread was inhibited. The infectious virus in the target organs decreased slightly. In ~,-CARtreated mice, infiltration of PMN did not occur nor was viral spread inhibited. The infectious virus in the target organs was equivalent to that in untreated control mice.
Discussion
The i.p. inoculation of virus has often been used to analyse systemic acute viral infection. Virus in the peritoneal cavity may or may not proliferate in the cavity, reach the target organs directly or haematogenously and proliferate in the organs. MCMV inoculated i.p. to newborn mice directly infected the liver (Mims et al., 1978) , whereas MCMV inoculated i.p. to 3-week-old or older mice reached the liver and other organs haematogenously within 24 h after inoculation. However, spread of virus inoculated i.p. has not been followed completely. As described in this paper, MCMV inoculated i.p. appeared in the plasma as early as 30 rain after the inoculation and the virus titre in the plasma peaked at 1 h. This early viral spread from the peritoneal cavity to the plasma was not cell-mediated, because cellassociated virus was almost negligible in the peripheral blood. In addition, virus titres in the target organs on the fourth day after inoculation were shown to depend on the titres in the plasma at 1 h after inoculation. Therefore, cell-free MCMV seemed to spread from the peritoneal cavity to the plasma lymphogenously in a similar way to other foreign substances.
In a previous paper (Hamasuna et al., 1993) , we reported that t-CAR showed protective effects against MCMV infection of mice. However, this protection was observed only when t-CAR was administered i.p. and then virus was also inoculated i.p. Thus, the protection with z-CAR might result from the inhibition of viral spread from the peritoneal cavity to the plasma. In fact, a 30-fold reduction in the titre of circulating MCMV and a shift in LDs0 greater than 20-fold were observed in z-CAR-treated mice. Additionally, the clearance of MCMV from the peritoneal cavity was slower in z-CARtreated mice than in untreated mice. The virus titre in the plasma was also lower in the former than in the latter until 2 h after inoculation, though MCMV appeared in plasma at the same time in both groups. The virus titres in the target organs depended on the amount of circulating MCMV in the plasma, irrespective of t-CAR treatment.
The association of the virus with PEC might contribute to inhibition of the early spread of MCMV from the peritoneal cavity to the plasma. In fact, the infectious centre assay revealed that macrophages in t-CAR-treated mice retained more MCMV than those in untreated mice. However, such virus was only a small portion of the inocula and almost all the virus in the peritoneal cavity remained cell-free even in the z-CAR-treated mice. Thus, it was unlikely that the association of MCMV with PEC resulted in the inhibition of viral spread from the peritoneal cavity to the plasma.
The viscosity of z-CAR might inhibit the spread of viruses in the peritoneal cavity. However, although K-CAR was as viscous as t-CAR, it did not show inhibition of spread. Thus, the viscosity of t-CAR could not explain the inhibition.
The infiltration of PMN into the peritoneal cavity paralleled the inhibition of viral spread fiom the peritoneal cavity to the plasma. The relationship of those two phenomena became more obvious when other types of CAR were administered to the mice. It was found that 2-CAR induced the .infiltration of PMN into the peritoneal cavity and int~ibition of viral spread from the peritoneal cavity to the plasma. In contrast, ~¢-CAR neither induced the infiltration of PMN nor inhibited the viral spread. Infiltration of PMN constitutes an acute inflammatory response. Inflammation localizes and eliminates causative agents (Whaley & Burt, 1992) . Therefore, when MCMV is inoculated i.p. into an inflammatory site, it might be localized in that site. However, although the mechanism of the inhibition of viral spread by l-CAR remains to be elucidated, it is tempting to conclude that inhibition of viral spread from the peritoneal cavity to the blood stream by z-CAR contributes to the z-CAR-induced protection of mice from lethal MCMV infection.
